Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $51.84 | 2 | 69.2% |
| Education | $23.12 | 2 | 30.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith+Nephew, Inc. | $51.84 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $23.12 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51.84 | 2 | Smith+Nephew, Inc. ($51.84) |
| 2021 | $23.12 | 2 | AstraZeneca Pharmaceuticals LP ($23.12) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2024 | Smith+Nephew, Inc. | HALO (Device) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Sports Med Resection | ||||||
| 07/23/2024 | Smith+Nephew, Inc. | HALO (Device) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Sports Med Resection | ||||||
| 05/03/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 03/16/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 729 | 782 | $43,173 | $14,410 |
| 2021 | 6 | 512 | 544 | $33,035 | $11,468 |
| 2020 | 6 | 351 | 370 | $23,498 | $7,768 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 65 | $19,741 | $6,443 | 32.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 30 | $7,154 | $2,404 | 33.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 223 | 228 | $6,384 | $2,183 | 34.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 224 | 229 | $4,809 | $1,631 | 33.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 143 | 143 | $3,432 | $1,177 | 34.3% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 84 | 87 | $1,653 | $571.37 | 34.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 57 | $15,561 | $5,774 | 37.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $5,205 | $1,809 | 34.8% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 155 | 157 | $4,519 | $1,518 | 33.6% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 157 | 159 | $3,464 | $1,144 | 33.0% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 101 | 101 | $3,123 | $838.48 | 26.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 58 | 59 | $1,163 | $384.72 | 33.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 46 | $11,805 | $3,820 | 32.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 22 | $3,849 | $1,241 | 32.2% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2020 | 101 | 101 | $2,929 | $1,015 | 34.7% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 101 | 101 | $2,222 | $759.78 | 34.2% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 63 | 63 | $1,953 | $676.98 | 34.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2020 | 37 | 37 | $740.00 | $255.42 | 34.5% |
About Dr. E. Carter, MD
Dr. E. Carter, MD is a Pulmonary Disease healthcare provider based in Riverside, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972540680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. E. Carter, MD has received a total of $74.96 in payments from pharmaceutical and medical device companies, with $51.84 received in 2024. These payments were reported across 4 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($51.84).
As a Medicare-enrolled provider, Carter has provided services to 1,592 Medicare beneficiaries, totaling 1,696 services with total Medicare billing of $33,646. Data is available for 3 years (2020–2022), covering 18 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Riverside, RI
- Active Since 06/01/2006
- Last Updated 09/13/2016
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1972540680
Products in Payments
- HALO (Device) $51.84
- BREZTRI (Drug) $23.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Riverside
Dr. Cedric Franklin Rutland, M.d, M.D
Pulmonary Disease — Payments: $2.6M
John Ladetto, M.d, M.D
Pulmonary Disease — Payments: $110,149
Corey Ventetuolo, M.d, M.D
Pulmonary Disease — Payments: $40,667
Kam Lau, Md, MD
Pulmonary Disease — Payments: $2,685
Mohammad Malekzadegan
Pulmonary Disease — Payments: $1,756
Dr. Ahmad Husari, Md, MD
Pulmonary Disease — Payments: $1,024